Polycomb factor PHF19 affects AML initiation, patient prognosis, and survival
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
From these data, we derived a prognostic signature—PHFScore—which reveals previously unrecognized AML survival-correlating genes that robustly stratify patients across distinct cellular origins and leukemogenic stages, underscoring Phf19’s key role in AML biology and prognosis.
Appeared: Sunday, October 25. Science Advances. Peer-reviewed journal.